Drug safety assessment of oral formulations of ketoconazole

Application of caspofungin in China compared with amphotericin B and fluconazole

(2014) Chunyu Zhang et al.   Therapeutics and Clinical Risk Management

Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating

(2013) Silvio Alencar Marques   ANAIS BRASILEIROS DE DERMATOLOGIA

Risk of oral antifungal agent-induced liver injury in Taiwanese

(2013) Wei-Yu Kao et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Coccidioidomycosis

(2012) Oliverio Welsh et al.   CLINICS IN DERMATOLOGY

Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection

(2010) J. L. Wang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Echinocandin Antifungal Drugs in Fungal Infections

(2010) Sharon C.-A. Chen et al.   DRUGS

Skin and Nail Mycoses: Treatment with Ketoconazole, a New Oral Antimycotic Agent: Haut- und Nagelmykosen: Behandlung mit Ketoconazole, einem neuen oralen Antimykotikum

(2010) A. A. Batter et al.   MYCOSES

New triazoles and echinocandins: mode of action,in vitroactivity and mechanisms of resistance

(2009) Maria Teresa Fera et al.   Expert Review of Anti-Infective Therapy

Drug-induced liver injury: Is it somehow foreseeable?

(2009) Giovanni Tarantino et al.   WORLD JOURNAL OF GASTROENTEROLOGY